BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Senesco Technologies, Inc. 

721 Route 202/206
Suite 130
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-864-4444 Fax: 908-864-4440


SEARCH JOBS








 Company News
Senesco Technologies, Inc. (SNT) Opens Two New Clinical Trial Sites And Initiates Treatment Of The First Patient In South Africa 3/12/2014 8:28:10 AM    More...
In Non-clinical Cancer Studies Senesco Technologies, Inc. (SNT)’s Therapeutic Candidate, SNS01-T, Works Synergistically In Combination With The Active Components Of Revlimid® And Velcade® 3/4/2014 8:47:37 AM    More...
Senesco Technologies, Inc. (SNT) Reports Second Quarter Of Fiscal Year 2014 Financial Results 2/18/2014 6:35:43 AM    More...
First Patient In Cohort 4 Receives Infusion Of Senesco Technologies, Inc. (SNT)’s Therapeutic Candidate, SNS01-T, For The Treatment Of Multiple Myeloma And Non-Hodgkins Lymphoma In Phase 1b/2a Clinical Trial 1/9/2014 10:18:05 AM    More...
Senesco Technologies, Inc. (SNT) To Present At Biotech Showcase™ 2014 1/9/2014 7:10:58 AM    More...
Senesco Technologies, Inc. (SNT), Fabrus LLC To Merge 12/30/2013 8:17:39 AM    More...
Senesco Technologies, Inc. (SNT) Announces Up To $25.2 Million Equity Financing 12/12/2013 6:50:32 AM    More...
Senesco Technologies, Inc. (SNT)'s Drug Candidate SNS01-T Selectively Kills Cancer Cells And Not Healthy Cells In Disease Models 12/10/2013 10:52:14 AM    More...
Senesco Technologies, Inc. (SNT) Announces Results Of Cohort 3 In SNS01-T Phase 1b/2a Trial 12/9/2013 10:05:43 AM    More...
Senesco Technologies, Inc. (SNT) Announces Results Of Cohort 3 In SNS01-T Phase 1b/2a Trial 12/9/2013 9:18:45 AM    More...
12345678910...

//-->